Valuation: Illumina, Inc.

Market Cap 26.71B 23.42B 21.59B 20.21B 37.9B 2,520B 38.69B 259B 100B 1,245B 100B 98.11B 4,318B P/E 2026 *
37.7x
P/E 2027 * 31.1x
Enterprise Value 27.23B 23.88B 22.01B 20.61B 38.64B 2,569B 39.44B 265B 102B 1,270B 102B 100B 4,403B EV / Sales 2026 *
5.96x
EV / Sales 2027 * 5.5x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day-0.62%
1 week+9.03%
Current month+8.34%
1 month+17.57%
3 months+50.04%
6 months+30.83%
Current year+34.61%
1 week 158.91
Extreme 158.91
182.84
1 month 155.55
Extreme 155.55
182.84
Current year 112.65
Extreme 112.65
182.84
1 year 88
Extreme 88
182.84
3 years 68.7
Extreme 68.7
195.64
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 2023-09-24
Director of Finance/CFO 50 2024-04-14
Chief Tech/Sci/R&D Officer 55 2025-05-28
Director TitleAgeSince
Director/Board Member 65 2016-07-27
Director/Board Member 66 2016-12-31
Director/Board Member 65 2019-02-04
Date Insider Type Main position Quantity % Market Cap.
Jun. 24Sell

General Counsel

-615 0.0004%
Jun. 15Free

Director

1,674 0.0011%
Jun. 04Sell

Head of Human Resources

-783 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
-0.62%+9.03%+86.25%-3.75% 26.71B
+1.44%+10.42%+25.66%+0.67% 191B
+1.25%-0.51%-24.17%+22.63% 143B
+1.75%+10.74%-1.31%-16.09% 139B
+0.07%-2.34%-58.48%-17.31% 65.74B
+1.18%+3.91%+16.07%+0.65% 52.27B
-0.52%-0.03%-27.04%-31.75% 43.55B
+0.37%+7.04%+14.13%+16.21% 38.41B
-0.66%+5.34%+6.24%+45.27% 36.76B
+1.26%+6.77%-11.59%-14.67% 29.91B
Average +0.55%+4.91%+2.58%+0.19% 76.62B
Weighted average by Cap. +0.98%+5.32%-0.27%+0.52%

Financials

2026 *2027 *
Net sales 4.57B 4.01B 3.69B 3.46B 6.48B 431B 6.62B 44.4B 17.18B 213B 17.16B 16.79B 739B 4.83B 4.24B 3.9B 3.65B 6.85B 456B 7B 46.92B 18.16B 225B 18.14B 17.74B 781B
Net income 723M 634M 585M 547M 1.03B 68.24B 1.05B 7.03B 2.72B 33.73B 2.72B 2.66B 117B 869M 762M 702M 657M 1.23B 81.96B 1.26B 8.44B 3.27B 40.51B 3.26B 3.19B 140B
Net Debt 522M 458M 422M 395M 741M 49.24B 756M 5.07B 1.96B 24.34B 1.96B 1.92B 84.38B -160M -140M -129M -121M -227M -15.07B -231M -1.55B -600M -7.45B -600M -587M -25.83B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
26-06-26 $176.55 -0.62% 2,196,286
26-06-25 $177.65 +1.46% 2,925,365
26-06-24 $175.09 +6.16% 2,646,306
26-06-23 $164.93 +2.20% 2,062,649
26-06-22 $161.38 -0.34% 1,791,164
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
176.55USD
Average target price
151.68USD
Spread / Average Target
-14.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock